AI Terminal
TRISTEL PLC
Report Publication Announcement • Oct 12, 2023
7990_rns_2023-10-12_70e020cc-09a4-4f49-a81e-eb6d8975906b.html
Report Publication Announcement
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 8486P
Tristel PLC
12 October 2023
Tristel plc
("Tristel" or the "Company")
Additional Investor Presentation
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the Company will deliver a Company Overview presentation at a hybrid event in London hosted by the UK Individual Shareholders' Society (ShareSoc) on Thursday 19 October 2023 and available to ShareSoc members via the link below:
Paul Swinney, Chief Executive Officer will deliver an "in-person" presentation which will also be streamed live (and recorded), allowing ShareSoc members to watch virtually.
Preliminary results for the year ended 30 June 2023 will be announced on Monday 16 October 2023 and no new material information will be disclosed in the presentation.
As previously announced the Company will also provide both an online presentation and in-person presentation open to all interested investors on Monday 16 October 2023. Further details can be found here:
https://tristelgroup.com/wp-content/uploads/2023/09/TSTL-Notice-of-results-FINAL.pdf
For further information please contact:
| ## Tristel plc | Tel: 01638 721 500 | |
| Paul Swinney, Chief Executive Officer | ||
| Liz Dixon, Chief Financial Officer | ||
| Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] | |
| Paul McManus | Mob: 07980 541 893 | |
| Lianne Applegarth | Mob: 07584 391 303 | |
| Charlotte Edgar | Mob: 07884 664 686 | |
| Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |
| Geoff Nash/Charlie Beeson (Corporate Finance) | ||
| Sunila de Silva (ECM) | ||
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAFFIFWFEDSEIS